UI researchers evaluate efficacy of failed Alzheimer’s clinical trial drug using rigorous pipeline
Most drugs developed to treat Alzheimer’s disease have been ineffective in clinical trials for years. Indiana University School of Medicine researchers recently evaluated the effectiveness of a failed clinical trial drug using their rigorous pipeline. Model Organism Development and Evaluation for Late-Onset Alzheimer’s Disease (MODEL-AD) investigators, a consortium of experts from the IU School of …